Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.
Burisch JStefania Chetcuti ZammitPierre EllulSvetlana TurcanDana DuricovaMartin BortlikKarina Winther AndersenVibeke AndersenIoannis P KaimakliotisMathurin FumeryCorinne Gower-RousseauGiulia GirardinDaniela ValpianiAdrian GoldisMarko BrinarSilvija Čuković-ČavkaPia OksanenPekka CollinLuisa BarrosFernando MagroRavi MisraNaila ArebiCarl ErikssonJonas HalfvarsonHendrika Adriana Linda KievitNatalia PedersenJens KjeldsenSally MyersShaji SebastianKonstantinos H KatsanosDimitrios K ChristodoulouJóngerð MidjordKári Rubek NielsenGediminas KiudelisLimas KupcinskasInna NikulinaElena BelousovaDoron SchwartzSelwyn OdesRiina SalupereAmalia CarmonaJuan R PinedaZsuzsanna VeghPeter L LakatosEbbe LangholzPia Munkholmnull nullPublished in: Journal of gastroenterology and hepatology (2019)
In a population-based inception cohort, 7% of IBD patients were not given a definitive diagnosis of IBD after 5 years of follow-up. One in four patients with IBDU eventually was classified as CD or UC. Overall, the disease course and medication burden in IBDU patients were mild.